These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7501268)

  • 1. Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist.
    Camacho-Ochoa M; Walker EL; Evans DL; Piercey MF
    Neurosci Lett; 1995 Aug; 196(1-2):97-100. PubMed ID: 7501268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.
    Ling ZD; Robie HC; Tong CW; Carvey PM
    J Pharmacol Exp Ther; 1999 Apr; 289(1):202-10. PubMed ID: 10087005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
    Wallace DR; Booze RM
    J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
    Piercey MF; Hyslop DK; Hoffmann WE
    Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
    Piercey MF; Walker EL; Feldpausch DL; Camacho-Ochoa M
    Neurosci Lett; 1996 Nov; 219(2):138-40. PubMed ID: 8971799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H](+)-7-OH-DPAT and [3H]pramipexole binding in the striatum and nucleus accumbens of Sprague-Dawley and Fischer-344 rats.
    Wallace DR; Owens J; Booze RM
    Life Sci; 1998; 63(19):PL275-80. PubMed ID: 9806230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons.
    Du F; Li R; Huang Y; Li X; Le W
    Eur J Neurosci; 2005 Nov; 22(10):2422-30. PubMed ID: 16307585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of repeated treatment with pramipexole on the central dopamine D3 system.
    Maj J; Rogói Z; Margas W; Kata M; Dziedzicka-Wasylewska M
    J Neural Transm (Vienna); 2000; 107(12):1369-79. PubMed ID: 11458990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats.
    Chang WL; Weber M; Breier MR; Saint Marie RL; Hines SR; Swerdlow NR
    Brain Res; 2012 Feb; 1437():69-76. PubMed ID: 22227455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain.
    Chernoloz O; El Mansari M; Blier P
    J Psychiatry Neurosci; 2012 Feb; 37(2):113-21. PubMed ID: 22023785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
    Booze RM; Wallace DR
    Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
    Mierau J; Schneider FJ; Ensinger HA; Chio CL; Lajiness ME; Huff RM
    Eur J Pharmacol; 1995 Jun; 290(1):29-36. PubMed ID: 7664822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain.
    Chernoloz O; El Mansari M; Blier P
    Neuropsychopharmacology; 2009 Feb; 34(3):651-61. PubMed ID: 18688211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
    Piercey MF; Hoffmann WE; Smith MW; Hyslop DK
    Eur J Pharmacol; 1996 Sep; 312(1):35-44. PubMed ID: 8891576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures.
    Ling ZD; Tong CW; Carvey PM
    Brain Res; 1998 Apr; 791(1-2):137-45. PubMed ID: 9593863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.
    Piercey MF
    Clin Neuropharmacol; 1998; 21(3):141-51. PubMed ID: 9617505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus.
    Flores G; Barbeau D; Quirion R; Srivastava LK
    J Neurosci; 1996 Mar; 16(6):2020-6. PubMed ID: 8604046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of dopamine D3 receptors in the islands of Calleja of the rat using quantitative receptor autoradiography.
    Hillefors-Berglund M; Von Euler G
    Eur J Pharmacol; 1994 Aug; 261(1-2):179-83. PubMed ID: 8001642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.